Strikingly, glial-specific IL-6 deletion led to a reduced tumor growth, which correlated with a reduction in SPP1+ TAMs while no effect was detected for C1Q+ TAMs (Fig. 3k-l). The gene discussed is SPP1; the disease is neoplasm.